USD 0.89
(7.23%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 82.86 Million USD | 97.93% |
2022 | -407.45 Million USD | -37.81% |
2021 | -713.05 Million USD | -70.45% |
2020 | 174.31 Million USD | 79.12% |
2019 | 97.31 Million USD | 16.17% |
2018 | 83.77 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 16.58 Million USD | -35.91% |
2024 Q3 | 1.12 Million USD | -129.45% |
2024 Q2 | 27.05 Million USD | 49.71% |
2023 Q4 | 23.72 Million USD | 181.74% |
2023 FY | - USD | 97.93% |
2023 Q3 | 8.41 Million USD | 0.73% |
2023 Q2 | 8.35 Million USD | -14.87% |
2023 Q1 | 9.81 Million USD | -29.62% |
2022 Q1 | -1.2 Million USD | -107.92% |
2022 Q2 | -12.23 Million USD | -919.75% |
2022 FY | - USD | -37.81% |
2022 Q4 | 13.95 Million USD | 54.95% |
2022 Q3 | 9 Million USD | 173.57% |
2021 FY | - USD | -70.45% |
2021 Q4 | 15.15 Million USD | 290.55% |
2021 Q3 | -7.95 Million USD | 25.0% |
2021 Q2 | -10.6 Million USD | -177.18% |
2021 Q1 | 13.73 Million USD | -68.0% |
2020 Q4 | 42.92 Million USD | -7.49% |
2020 Q2 | 30.45 Million USD | 35.62% |
2020 FY | - USD | 79.12% |
2020 Q1 | 22.45 Million USD | 0.0% |
2020 Q3 | 46.4 Million USD | 52.39% |
2019 FY | - USD | 16.17% |
2018 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
American Oncology Network, Inc. | -39.35 Million USD | 310.584% |
Assure Holdings Corp. | -19.82 Million USD | 518.014% |
Novo Integrated Sciences, Inc. | -5.84 Million USD | 1516.772% |
Panamera Holdings Corporation | -7.12 Million USD | 1263.753% |